Author:
Haller D.G.,O'Connell M.J.,Cartwright T.H.,Twelves C.J.,McKenna E.F.,Sun W.,Saif M.W.,Lee S.,Yothers G.,Schmoll H.-J.
Funder
Genentech, Inc.
National Cancer Institute
Department of Health and Human Services
Sanofi-Synthelabo, Inc.
Genentech, Inc
Chugai
F. Hoffmann-La Roche Ltd/Genentech, Inc.
AVANT
F. Hoffmann-La Roche Ltd
Reference23 articles.
1. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer;André;N Engl J Med,2004
2. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial;André;J Clin Oncol,2009
3. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer;Haller;J Clin Oncol,2011
4. Capecitabine plus oxaliplatin (XELOX) versus bolus 5-fluorouracil/leucovorin (5-FU/LV) as adjuvant therapy for stage III colon cancer: survival follow-up of study NO16968 (XELOXA);Schmoll;J Clin Oncol,2012
5. Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses;Yothers;J Clin Oncol,2011
Cited by
105 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Differences in characteristics and outcomes between early-onset colorectal cancer and late-onset colorectal cancers;European Journal of Surgical Oncology;2024-09
2. Prognosis of early-onset vs. late-onset stage II/III colorectal cancer patients with adjuvant chemotherapy: a multicenter propensity score matched study;International Journal of Clinical Oncology;2024-08-14
3. Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials;Journal of Clinical Oncology;2024-07-01
4. Non-metastatic colon cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatments, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, AFEF, and SFR);Digestive and Liver Disease;2024-05
5. Adjuvant Chemotherapy for Older Patients With Stage III Colorectal Cancer: A Real-World Analysis of Treatment Recommendations, Treatment Administered and Impact on Cancer Recurrence;Clinical Colorectal Cancer;2024-03